Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Chongqing Xishan Science & Technology Co. Ltd. currently has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This single active matter is assigned to 1 distinct examiner, indicating a concentrated prosecution profile for its current filings. The portfolio is also limited to 1 distinct art unit, which suggests that the company's current innovations fall under a specific technical classification. This structure simplifies the prosecution process by focusing on the requirements of a single art unit. Such a focused approach allows the company to dedicate its resources to a single active matter.
The busiest examiner for Chongqing Xishan Science & Technology Co. Ltd. is MCCORMACK, ERIN KATHLEEN, who is managing the 1 busiest examiner pending action. As the only examiner currently reviewing the company's work, MCCORMACK, ERIN KATHLEEN holds the entire active workload. For the applicant, this means that the success of the current prosecution depends on the specific interpretations and standards of this individual. The presence of 1 distinct examiner and 1 distinct art unit highlights a focused strategy for patent acquisition in the medical device sector. Practitioners should focus on the specific examination style of MCCORMACK, ERIN KATHLEEN.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCORMACK, ERIN KATHLEEN | 1 | 7.9% | +50.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18559142 | ELECTROSURGICAL BIOPSY NEEDLE, ELECTROSURGICAL BIOPSY NEEDLE KIT, AND VACUUM-ASSISTED BREAST BIOPSY SYSTEM | MCCORMACK, ERIN KATHLEEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18559142 | ELECTROSURGICAL BIOPSY NEEDLE, ELECTROSURGICAL BIOPSY NEEDLE KIT, AND VACUUM-ASSISTED BREAST BIOPSY SYSTEM | MCCORMACK, ERIN KATHLEEN | — |
| Art Unit | Apps |
|---|---|
| 3791 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18559142 | ELECTROSURGICAL BIOPSY NEEDLE, ELECTROSURGICAL BIOPSY NEEDLE KIT, AND VACUUM-ASSISTED BREAST BIOPSY SYSTEM | MCCORMACK, ERIN KATHLEEN | 3791 | §103§112 | Final Rejection | — | Pending | Nov 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialChongqing Xishan Science & Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Erin Kathleen Mccormack has the most, with 1 of Chongqing Xishan Science & Technology Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
